Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

By sjmartinez • November 28, 2024

Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O; PURPOSE 2 Study Team. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. N Engl J Med. 2024 Nov 27. doi: 10.1056/NEJMoa2411858. Epub ahead of print. PMID: 39602624.

Tags: Infectious Diseases, Publications

Related Posts

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Doni Jayavelu N, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E,[...]

The HosA histone deacetylase regulates stress resistance, host cell interactions, and virulence in Aspergillus fumigatus

Liu H, Lee P, Vo A, Paul S, Phan QT, Lin J, Bruno VM, Stamnes MA, Moye-Rowley WS, Filler SG. The HosA histone deacetylase regulates[...]

The Medicine for a Changing Planet curriculum: a mixed methods evaluation

Benzekri NA, Tin AH, Judson SD, Ripp K, Xie M, Veidis E, Barry M, Rabinowitz P. The Medicine for a Changing Planet curriculum: a mixed[...]